Get started
yourpalVal

VINC breaking out soon?

Long
Vincerx Pharma, Inc. (NASDAQ:VINC)  
yourpalVal  
NASDAQ:VINC   Vincerx Pharma, Inc.
Fundamental Analysis PHARMA biomed
1
0
fundamental pharma biomed
Very little to be found on this one fundamentally, as to what the catalyst could be.
But SEC forms show numerous insiders (including CEO) buying before Christmas. Today, analyst Geulah Livshits from Chardan Capital released a buy rating with a PT of 33.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.